Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains

Virology

Volumn 268, Issue 1, 2000, Pages 17-28

  Ellison, Aaron R ^a   Yang, Li ^a   Voytek, Cynthia ^a   Margolis, Todd P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; INCUBATION TIME; INFECTION SENSITIVITY; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS DETECTION; VIRUS PATHOGENESIS;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1;

EID: 0034007315     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0158     Document Type: Article

References (62)

1. Abghari S. Z., Stulting R. D. Spread of HSV and establishment of latency after corneal infection in inbred mice. Invest. Ophthalmol. Visual Science 27:1986;77-82
2. Abghari S. Z., Stulting R. D. Variation in the number of sites of latency of herpes simplex virus in trigeminal ganglia of inbred mice. Curr. Eye Res. 7:1988;1155-1162
3. Altmann D. M., Blyth W. A. Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance. J. Gen. Virol. 66:1985;1297-1303
4. Barbosa M. D., Nguyen Q. A., Tchernev V. T., Ashley J. A., Detter J. C., Blaydes S. M., Brandt S. J., Chotai D., Hodgman C., Solari R. C., Lovett M., Kingsmore S. F. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 382:1996;262-265
5. Bishop G. A., McCurry L., Schwartz S. A., Glorioso J. C. Activation of human natural killer cells by herpes simplex virus type 1-infected cells. Intervirology. 28:1987;78-88
6. Borrow P., Oldstone M. B. A. Lymphocytic choriomeningitis virus. Nathanson N., Ahmed R., Gonzalez-Scarano F., Griffen D. E., Holmes K. V., Murphy F. A., Robinson H. L. Viral Pathogenesis. 1997;593-627 Lipincott-Raven, Philadelphia
7. Bouley D. M., Kanangat S., Wire W., Rouse B. T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:1995;3964-3971
8. Bukowski J. F., Welsh R. M. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 136:1986;3481-3485
9. Canessa A., Chatterjee S., Whitley R. J., Prasthofer E. F., Grossi C. E., Tilden A. B. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon. Viral Immunol. 3:1990;217-224
10. Cantin E. M., Hinton D. R., Chen J., Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:1995;4898-4905
11. Chan W. L., Ziltener H. J., Liew F. Y. Interleukin-3 protects mice from acute herpes simplex virus infection. Immunology. 71:1990;358-363
12. Colmenares C., Lopez C. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. J. Immunol. 136:1986;3473-3480
13. Cunningham E. T. Jr., De Souza E. B. Localization of type I IL-1 receptor mRNA in brain and endocrine tissues using in situ hybridization histochemistry. De Souza E. B. Methods in Neuroscience. Neurobiology of Cytokines, Part A. 1994;112-127 CRC Press, New York
14. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science. 259:1993;1739-1742
15. Elin R. J., Edelin J. B., Wolff S. M. Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect. Immun. 10:1974;88-91
16. Engler H., Zawatzky R., Kirchner H., Armerding D. Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch. Virol. 74:1982;239-247
17. Feduchi E., Alonso M. A., Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1989;1354-1359
18. Gallin J. I., Bujak J. S., Patten E., Wolff S. M. Granulocyte function in the Chediak-Higashi syndrome of mice. Blood. 43:1974;201-206
19. Geiger K., Howes E. L., Sarvetnick N. Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections. J. Virol. 68:1994;5556-5567
20. Geiger K. D., Nash T. C., Sawyer S., Krahl T., Patstone G., Reed J. C., Krajewski S., Dalton D., Buchmeier M. J., Sarvetnick N. Interferon-γ protects against herpes simplex virus type 1-mediated neuronal death. Virology. 238:1997;189-197
21. Gesser R. M., Valyi-Nagy T., Fraser N. W. Restricted herpes virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology. 200:1994;791-795
22. Halford W. P., Gebhardt B. M., Carr D. J. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology. 238:1997;53-63
23. Hoskin D. W., Anderson S. K., Stankova J., Haliotis T., Roder J. C. Immunologic and nonimmunologic consequences of the beige mutation. Rihova B., Vetvicka V. Immunologic Disorders in Mice. 1991;251-263 CRC Press, Boca Raton
24. Kägi D., Ledermann B., Bürki K., Seiler P., Odermatt B., Olsen K. J., Podack E. R., Zinkernagel R. M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37
25. Kapoor A. K., Nash A. A., Wildy P. Pathogenesis of herpes simplex virus in B cell-suppressed mice: The relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 61:1982;127-131
26. Kastrukoff L. F., Lau A. S., Puterman M. L. Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice. J. Gen. Virol. 67:1986;613-621
27. Katz J. P., Bodin E. T., Coen D. M. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J. Virol. 64:1990;4288-4295
28. Kodukula P., Lui T., Van Rooijen N., Jager M. J., Hendricks R. L. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162:1999;2895-2905
29. Kramer M. F., Coen D. M. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1995;1389-1399
30. Liu T., Tang Q., Hendricks R. L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:1996;264-271
31. Lopez C. Genetics of natural resistance to herpes simplex virus infections in mice. Nature. 258:1975;152-153
32. Maggioncalda J., Mehta A., Su Y. H., Fraser N. W., Block T. M. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology. 225:1996;72-81
33. Mahoney K. H., Morse S. S., Morahan P. S. Macrophage functions in beige (Chediak-Higashi syndrome) mice. Cancer Res. 40:1980;3934-3939
34. Margolis T. P., Sedarati F., Dobson A. T., Feldman L. T., Stevens J. G. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology. 189:1992;150-160
35. Mehta A., Maggioncalda J., Bagasra O., Thikkavarapu S., Saikumari P., Valyi-Nagy T., Fraser N. W., Block T. M. In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology. 206:1995;633-640
36. Minagawa H., Sakuma S., Mohri S., Mori R., Watanabe T. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID). Arch. Virol. 103:1988;73-82
37. Morahan P. S., Coleman P. H., Morse S. S., Volkman A. Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: Effects of immunomodulators in beige mice and 89Sr-treated mice. Infect. Immun. 37:1982;1079-1085
38. Perou C. M., Leslie J. D., Green W., Li L., Ward D. M., Kaplan J. The beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J. Biol. Chem. 272:1997;29790-29794
39. Rager-Zisman B., Quan P.-C., Rosner M., Moller J. R., Bloom B. R. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol. 138:1987;884-888
40. Ramakrishnan R., Poliani P. L., Levine M., Glorioso J. C., Fink D. J. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J. Virol. 70:1996;6519-65123
41. Roder J., Duwe A. K. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 278:1979;451-453
42. Rossol-Voth R., Rossol S., Schutt K. H., Corridori S., de Cian W., Falke D. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:1991;143-147
43. Sawtell N. M. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J. Virol. 71:1997;5423-5431
44. Sawtell N. M. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72:1998;6888-6892
45. Schmid D. S., Rouse B. T. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:1992;57-74
46. Scott P. Selective differentiation of CD4+ T helper cell subsets. Curr. Opin. Immunol. 5:1993;391-397
47. Sekizawa T., Openshaw H., Wohlenberg C., Notkins A. L. Latency of herpes simplex virus in absence of neutralizing antibody: Model for reactivation. Science. 210:1980;1026-1028
48. Shimeld C., Whiteland J. L., Williams N. A., Easty D. L., Hill T. J. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol. 78:1997;3317-3325
49. Simmons A. H-2-linked genes influence the severity of herpes simplex virus infection of the peripheral nervous system. J. Exp. Med. 169:1989;1503-1507
50. Simmons A., Tscharke D., Speck P. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. Curr. Top. Microbiol. Immunol. 179:1992;31-56
51. Smith P. M., Wolcott R. M., Chervenak R., Jennings S. R. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology. 202:1994;76-88
52. Speck P. G., Simmons A. Synchronous appearance of antigen-positive and latently infected neurons in spinal ganglia of mice infected with a virulent strain of herpes simplex virus. J. Gen. Virol. 73:1992;1281-1285
53. Sprecher E., Becker Y. Induction of interleukin-1 alpha and beta gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1. Arch. Virol. 110:1990;259-269
54. Steiner I., Spivack J. G., Deshmane S. L., Ace C. I., Preston C. M., Fraser N. W. A herpes simplex virus type 1 mutant containing a nontransducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J. Virol. 64:1990;1630-1638
55. Stevens J. G., Wagner E. K., Devi-Rao G. B., Cook M. L., Feldman L. T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science. 235:1987;1056-1059
56. Tamesis R. R., Messmer E. M., Rice B. A., Dutt J. E., Foster C. S. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice. Eye. 8:1994;298-306
57. Tang J., DeLong D. C., Butler L. D., Marder P., Ades E. W. Murine thymocytes mediate a natural killer-like activity against herpes virus-infected target cells but not YAC-1 target cells. Scand. J. Immunol. 24:1986;115-118
58. Thomas E. E., Lau A. S., Kim S. U., Osborne D., Kastrukoff L. F. Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice. J. Gen. Virol. 72:1991;2051-2057
59. Valyi-Nagy T., Deshmane S. L., Raengsakulrach B., Nicosia M., Gesser R. M., Wysocka M., Dillner A., Fraser N. W. Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J. Virol. 66:1992;7336-7345
60. Wagner E. K., Bloom D. C. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10:1997;419-443
61. Welsh R. M., Sen G. C. Nonspecific host response to viral infection. Nathanson N., Ahmed R., Gonzalez-Scarano F., Griffen D. E., Holmes K. V., Murphy F. A., Robinson H. L. Viral Pathogenesis. 1997;109-141 Lippincott-Raven, Philadelphia
62. Wilkie N. M., Clements J. B., Boll W., Mantei N., Weissmann C. Hybrid plasmid containing an active thymidine kinase gene of herpes simplex virus 1. Nucleic Acids Res. 7:1979;859-877